Bromfenac ophthalmic solution is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Bromfenac Sodium
Specifications
Human
Injectable
Commercial
FEATURED Products
Related Media
New Product Development
Where our FDA approved laboratory begins developing products, formulating and validating methods to ensure quality.
Compliance Audits
Where we audit and champion our partner factories to exceed cGMP standards set by authorities.
Regulatory Services
Where all submissions are filed with the knowledge and experience of our 550+ worldwide approvals on record.